News

Filter

1 to 9 of 113 results

Actavis confirms generic Uceris patent challenge

Actavis confirms generic Uceris patent challenge

25-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that it has filed an Abbreviated New…

ActavisCosmo TechnologiesGastro-intestinalsGenericsPatentsRegulationSalix PharmaceuticalsSantarusUcerisUSAValeant Pharmaceuticals International

US DEA de-schedules AstraZeneca’s Movantik

07-02-2015

The USA’s Drug Enforcement Administration (DEA) has de-scheduled UK pharma major AstraZeneca’s Movantik…

AstraZenecaGastro-intestinalsMovantiknaloxegolNektar TherapeuticsPharmaceuticalRegulationUSA

US FDA approves first generic of AstraZeneca’s Nexium

US FDA approves first generic of AstraZeneca’s Nexium

27-01-2015

The US Food and Drug Administration yesterday approved a generic version of Nexium (esomeprazole), Anglo-Swedish…

AstraZenecaGastro-intestinalsGenericsNexiumRegulationTeva Pharmaceutcal IndustriesUSA

AstraZeneca files marketing authorization application with EMA for lesinurad

AstraZeneca files marketing authorization application with EMA for lesinurad

22-01-2015

The European Medicines Agency has accepted the marketing authorization application by AstraZeneca for…

AstraZenecaGastro-intestinalslesinuradPharmaceuticalRegulation

FDA committee votes to not recommend Ferring’s desmopressin

FDA committee votes to not recommend Ferring’s desmopressin

15-01-2015

The US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has…

desmopressinFerring PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

Takeda gains approval for Takecab in Japan; files MS drug NDA

Takeda gains approval for Takecab in Japan; files MS drug NDA

29-12-2014

Japan’s largest drugmaker Takeda Pharmaceutical and partner Otsuka Pharmaceuticals have been granted…

Gastro-intestinalsGlatiramer AcetateJapanNeurologicalOtsuka PharmaceuticalsPharmaceuticalRegulationTakecabTakeda PharmaceuticalTeva Pharmaceuticals Industriesvonoprazan

NICE opens consultation on Millennium’s Crohn’s drug Entyvio

23-12-2014

In draft guidance issued today, UK health costs watchdog the National Institute for Health and Care Excellence…

BiotechnologyEntyvioGastro-intestinalsMillennium PharmaceuticalsPricingRegulationTakeda PharmaceuticalUK

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

NICE says ‘yes’ to Remicade, Humira and Simponi for ulcerative colitis

12-12-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

AbbVieGastro-intestinalsHumiraMerck & CoPharmaceuticalPricingRegulationRemicadeSimponi InjectionUK

1 to 9 of 113 results

COMPANY SPOTLIGHT

Menarini

Back to top